Prestige enters agreements with Pharmapark and Munipharma for Tuznue®

Jul 2, 2019

Prestige announces agreements with Pharmapark and Mundipharma for the supply and commercialisation of Tuznue® . An agreement reached with Pharmapark allows for supply and commercialisation in Russia, while the agreement with Mundipharma grants an exclusive license and supply of the drug.

Print Page Mail Article